These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3738862

  • 1. Pasteurisation induced changes in an antithrombin III concentrate.
    Winkelman L, Haddon ME.
    Thromb Res; 1986 Jul 15; 43(2):219-27. PubMed ID: 3738862
    [Abstract] [Full Text] [Related]

  • 2. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
    Lane DA, Flynn A, Ireland H, Erdjument H, Samson D, Howarth D, Thompson E.
    Br J Haematol; 1987 Apr 15; 65(4):451-6. PubMed ID: 3580302
    [Abstract] [Full Text] [Related]

  • 3. Separation of active and inactive forms of human antithrombin by heparin affinity chromatography.
    Heger A, Grunert T, Schulz P, Josic D, Buchacher A.
    Thromb Res; 2002 Apr 15; 106(2):157-64. PubMed ID: 12182916
    [Abstract] [Full Text] [Related]

  • 4. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.
    Collen D, Schetz J, de Cock F, Holmer E, Verstraete M.
    Eur J Clin Invest; 1977 Feb 15; 7(1):27-35. PubMed ID: 65284
    [Abstract] [Full Text] [Related]

  • 5. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW.
    Thromb Haemost; 1980 Feb 29; 42(5):1434-45. PubMed ID: 7368150
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the biological activity of antithrombin III in patients with hepatic cirrhosis.
    Matsuo T, Matsuo C, Matsuo O.
    Clin Chim Acta; 1984 Jul 16; 140(2):125-32. PubMed ID: 6467606
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine.
    Okajima Y, Kanayama S, Maeda Y, Urano S, Kitani T, Watada M, Nakagawa M, Ijichi H.
    Thromb Res; 1984 Jul 16; 24(1-2):21-9. PubMed ID: 7330836
    [No Abstract] [Full Text] [Related]

  • 9. Further characterization of a pathological isoantithrombin with no affinity for heparin (antithrombin III Roma).
    De Stefano V, Leone G, Ferrelli R, Di Donfrancesco A, De Martini D, Bizzi B.
    Thromb Res; 1987 Oct 01; 48(1):23-30. PubMed ID: 3424283
    [Abstract] [Full Text] [Related]

  • 10. Commercial antithrombin concentrate contains inactive L-forms of antithrombin.
    Chang WS, Harper PL.
    Thromb Haemost; 1997 Feb 01; 77(2):323-8. PubMed ID: 9157590
    [Abstract] [Full Text] [Related]

  • 11. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M, Petersen LC, Thorsen S.
    J Lab Clin Med; 1984 Aug 01; 104(2):245-56. PubMed ID: 6747440
    [Abstract] [Full Text] [Related]

  • 12. A single-step method for the isolation of antithrombin III.
    Wickerhauser M, Williams C.
    Vox Sang; 1984 Aug 01; 47(6):397-405. PubMed ID: 6516292
    [Abstract] [Full Text] [Related]

  • 13. Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'.
    Koide T, Takahashi K, Odani S, Ono T, Sakuragawa N.
    Thromb Res; 1983 Jul 15; 31(2):319-28. PubMed ID: 6636046
    [Abstract] [Full Text] [Related]

  • 14. Studies of the heterogeneity of antithrombin III concentrates.
    Barrowcliffe TW, Eggleton CA, Mahmoud M.
    Br J Haematol; 1983 Sep 15; 55(1):37-46. PubMed ID: 6882687
    [Abstract] [Full Text] [Related]

  • 15. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
    Aiach M, François D, Priollet P, Capron L, Roncato M, Alhenc-Gelas M, Fiessinger JN.
    Br J Haematol; 1987 Aug 15; 66(4):515-22. PubMed ID: 3663508
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.